Clinical trial · Interventional
A New Method: the Third Space Robotic and Endoscopic Cooperative Surgery (TS-RECS)
Feasibility of the Third Space Robotic and Endoscopic Cooperative Surgery(TS-RECS) for Treating Gastric Stromal Tumor
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The third space robotic and endoscopic cooperative surgery (TS-RECS) combines the endoscopic techniques and the merits of Da Vinci surgical robot, such as flexible and precise instruments, tremors filtering system and a 3-D surgical view. TS-RECS takes full advantage of the methodology of the third space, making it possible to dissect gastric GISTs (gastrointestinal stromal tumors) entirely without the damage of mucosal layer. Here, this study preliminarily assessed the feasibility, safety and effectivity of the novel hybrid operation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Soft Tissue Neoplasm | Gastric Soft Tissue Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| the third space robotic and endoscopic cooperative surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- patients received treatment of TS-RECS
- interventionNames
- Procedure: the third space robotic and endoscopic cooperative surgery
Primary outcomes (1)
- measure
- the rate of adverse events
- timeFrame
- through study completion, an average of 6 months
- description
- Adverse events included intraoperative adverse (full-thickness perforation, hemorrhage, injury of visceral organs and vessel, and anaesthesia complications), and postoperative adverse events (infectious complications, intra-abdominal /intraluminal bleeding, gastric stasis and leakage)
Secondary outcomes (6)
- measure
- rate of en bloc resection
- timeFrame
- 1 day
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with gastric GISTs originating from muscularis propria diagnosed by EUS (endoscopic ultrasound)； * The maximal cross-sectional diameter of tumor ranging from 2cm to 5cm, or the maximal cross-sectional diameter of tumor \<2cm but with malignant potential ( irregular shape, cystic space, heterogeneity and rapid growth during follow-ups ) ； * No evidence of tumor metastasis on all per-operative evaluations； Exclusion Criteria: * 1\. Patients with serious systemic comorbidities, such as severe heart failure, respiratory failure, uncontrolled hypertension; * 2\. Patients with advanced malignant tumor; * 3\. Patients were required the emergency operation by complete intestinal obstruction, perforation and hemorrhage caused by the tumor; * 4.Patients with ulcer penetration into tumors; * 5\. Patients with the contraindications for general anesthesia; * 6\. Patients were pregnant or younger than 18 years old；
References
Publications (1)
- DERIVEDShi F, Li Y, Pan Y, Sun Q, Wang G, Yu T, Shi C, Li Y, Xia H, She J. Clinical feasibility and safety of third space robotic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumors dissection : A new surgical technique for treating gastric GISTs. Surg Endosc. 2019 Dec;33(12):4192-4200. doi: 10.1007/s00464-019-07223-w. Epub 2019 Oct 17. PMID 31624942